Treatment of Diabetic Dyslipidemia

This publication has 19 references indexed in Scilit:

• Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
  Diabetes Care, 1997
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
  JAMA, 1993
• Management of Dyslipidemia in NIDDM
  Diabetes Care, 1990
• HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia
  New England Journal of Medicine, 1988
• Lovastatin for Lowering Cholesterol Levels in Non-Insulin-Dependent Diabetes Mellitus
  New England Journal of Medicine, 1988
• Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis
  Metabolism, 1987
• The Lipid Research Clinics Coronary Primary Prevention Trial Results
  JAMA, 1984
• Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
  Proceedings of the National Academy of Sciences, 1983
• Evidence for diabetes mellitus and genetic forms of hypertriglyceridemia as independent entities
  Metabolism, 1975